New advances in small molecule drugs targeting NMDA receptors
7.4
来源：
Nature
关键字：
AI brain science
发布时间：
2025-11-04 19:32
摘要：
Recent advances in small-molecule drugs targeting NMDA receptors highlight their potential in treating depression and other CNS disorders. The article reviews various modulators, including channel blockers and allosteric modulators, emphasizing their therapeutic implications and ongoing clinical developments. Notably, the research indicates a growing interest in NMDA receptor modulation, particularly for depression, showcasing significant innovation and clinical relevance in brain science.
原文：
查看原文
价值分投票
评分标准
新闻价值分采用0-10分制，综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。
评分越高，表示该新闻的价值越大，越值得关注。
价值维度分析
domain_focus
1.0分+1.0分
business_impact
0.5分+0.5分
scientific_rigor
1.5分+1.5分
timeliness_innovation
1.5分+1.5分
investment_perspective
2.5分+2.5分
market_value_relevance
1.0分+1.0分
team_institution_background
0.5分+0.5分
technical_barrier_competition
1.0分+1.0分
关键证据
Substantial progress has been made in the clinical development of small-molecule modulators targeting NMDA receptors.
Among various therapeutic indications, depression has emerged as an especially active area of investigation.
These developments reflect the maturation of NMDA receptor pharmacology and reaffirm the broad therapeutic potential.
真实性检查
否
AI评分总结
Recent advances in small-molecule drugs targeting NMDA receptors highlight their potential in treating depression and other CNS disorders. The article reviews various modulators, including channel blockers and allosteric modulators, emphasizing their therapeutic implications and ongoing clinical developments. Notably, the research indicates a growing interest in NMDA receptor modulation, particularly for depression, showcasing significant innovation and clinical relevance in brain science.